论文部分内容阅读
目的给予失眠症患者临床治疗,评定其临床治疗效果,总结有效的治疗方法。方法 66例失眠症患者,利用抽签法将患者随机分为观察组与对照组,各33例。对照组患者给予阿普唑仑治疗,观察组给予患者酒石酸唑吡坦片(思诺思片)治疗,对比分析两组患者治疗后的组间数据。结果两组患者7 d治疗后,观察组患者的临床总有效率为96.97%显著高于对照组患者的78.79%,差异有统计学意义(P<0.05)。观察组不良反应发生率为9.09%,观察组不良反应发生率为18.18%,两组比较差异无统计学意义(P>0.05)。结论给予失眠症患者思诺思治疗的安全性以及临床疗效均显著高于阿普唑仑治疗,更具有临床推广意义。
Objective To give clinical treatment of patients with insomnia, assess the clinical treatment effect, summarize the effective treatment. Methods Sixty-six patients with insomnia were randomly divided into observation group and control group by using the method of lottery, with 33 cases in each. Patients in the control group were treated with alprazolam, while patients in the observation group were treated with zolpidem tartrate tablets (SiNOX tablets). The data of two groups were compared after treatment. Results After 7 days of treatment, the total clinical effective rate in the observation group was 96.97%, which was significantly higher than that in the control group (78.79%), the difference was statistically significant (P <0.05). The incidence of adverse reactions in the observation group was 9.09%, and the incidence of adverse reactions in the observation group was 18.18%. There was no significant difference between the two groups (P> 0.05). Conclusions The safety and clinical efficacy of SiNOX therapy in patients with insomnia are significantly higher than that of alprazolam treatment, which has clinical significance.